![De Wei Kong](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
De Wei Kong
Director/Board Member at Beijing Zhendong Langdi Pharmaceutical Co., Ltd.
Profile
De Wei Kong currently works at Beijing Zhendong Langdi Pharmaceutical Co., Ltd., as Member-Supervisory Board.
De Wei Kong active positions
Companies | Position | Start |
---|---|---|
Beijing Zhendong Langdi Pharmaceutical Co., Ltd.
![]() Beijing Zhendong Langdi Pharmaceutical Co., Ltd. Pharmaceuticals: OtherHealth Technology Part of Fountainvest Partners (Asia) Ltd., Beijing Zhendong Langdi Pharmaceutical Co., Ltd. manufactures medicinal chemicals and botanical products. The company is based in Beijing, China. Beijing Zhendong Langdi Pharmaceutical Co. was acquired by Shanghai Fanglang Enterprise Management Co. Ltd. from Shanxi Zhendong Pharmaceutical Co., Ltd. on October 28, 2021 for $895.09 million. The Chinese company was founded in 2003. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Beijing Zhendong Langdi Pharmaceutical Co., Ltd.
![]() Beijing Zhendong Langdi Pharmaceutical Co., Ltd. Pharmaceuticals: OtherHealth Technology Part of Fountainvest Partners (Asia) Ltd., Beijing Zhendong Langdi Pharmaceutical Co., Ltd. manufactures medicinal chemicals and botanical products. The company is based in Beijing, China. Beijing Zhendong Langdi Pharmaceutical Co. was acquired by Shanghai Fanglang Enterprise Management Co. Ltd. from Shanxi Zhendong Pharmaceutical Co., Ltd. on October 28, 2021 for $895.09 million. The Chinese company was founded in 2003. | Health Technology |
- Stock Market
- Insiders
- De Wei Kong